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The recently implemented National Health Act1  (hereafter 
called ’the Act’ creates a legal framework for human subjects 
research including research involving children. Most of the 
Act came into operation on 2 May 2005. However, section 
71, which deals with research involving human subjects, will 
only come into operation in the future. Section 71(3) sets out 
the conditions for ‘non-therapeutic research’ (NTR) which 
includes an obligation to obtain consent from the Minister of 
Health (hereafter called ‘the Minister’). The Minister has to 
determine if NTR involving minors meets scientific, ethical and 
public policy justifications. Any NTR with minors that does 
not receive ministerial consent will be unlawful. This article 
describes the ethical-legal problems relating to so-called non-
therapeutic child research. It critically examines section 71(3) of 
the Act and outlines various options for law reform. 
NTR involving children – necessary 
but a vexing ethical-legal problem
The Department of Health’s Health Research Policy in South 
Africa2 identifies research into preventable diseases as a key 
objective. Much of this research will be conducted with healthy 
volunteers (like vaccine research) or hold little direct benefit 
for volunteers (like most phase I drug studies). However this 
research is part of South Africa’s overall public health strategy. 
In addition, the Medicines Control Council increasingly 
requires child data before it will license products for this age 
category.3 
The law and guidelines, however, have struggled to define 
when children can participate in NTR. Currently, there are 
no legal guidelines on child research (until section 71 of the 
Act becomes operational). Legal scholars have generally 
recommended the limited involvement of minors in NTR, 
namely in low-risk research and with proxy consent.4,5 
Scholars have also tried to establish the age at which children 
may consent independently to NTR. Some have argued that 
children of any age may consent to NTR of no risk,6 while 
others have argued that persons under 18 should never consent 
independently to NTR.5
Ethical guidance on this issue is not completely 
harmonised.7-10 Most guidelines maintain that when the 
research does not hold out direct benefit, the permissible risk 
level is a minor increase over the risks of daily life or routine 
medical and psychological tests.7-9 Only the Medical Research 
Council’s general principles do not permit any such increase.11 
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The new National Health Act has clarified that children may 
take part in ‘non-therapeutic’ research (NTR) and the age 
at which they may provide independent consent to such 
research, viz. at legal majority. However, the Act will require 
consent from the Minister of Health for all research classed 
as NTR and involving minors regardless of the level of risk. 
This requirement is overly broad. It will require that low-risk 
research without direct benefits, which might be adequately 
reviewed by an accredited research ethics committee (REC), 
must also be reviewed by the Minister. As it currently stands 
this requirement serves no plausible ethical purpose, will 
cause delays and discourage essential research on the needs of 
children, and may inspire researchers and RECs alike to ‘foil 
the system’. We argue that in the long term there should be 
comprehensive law reform for child research. However, in the 
short term, amendments should be made to the Act to narrow 
the scope of this provision. The amendment should require 
ministerial consent for research that is currently not approvable 
by an REC in terms of national ethical guidelines, namely, 
research that does not hold out direct benefit but presents 
more than a minor increase over minimal risk. If our law 
reform recommendations are rejected, we favour the delegation 
of this task to RECs because, if they receive appropriate 
training, they should be competent to conduct it. We accept 
the disadvantages, namely that the same body will review 
protocols twice from slightly different perspectives and that 
certain categories of research will remain unapprovable.  
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Given this ambiguous guidance, research ethics committees 
(RECs) have made varied judgements on this issue. 
The National Health Act – an attempt 
to clarify the participation of minors in 
NTR?
The Act has clarified some of the ethical-legal ambiguities 
relating to NTR. It has, firstly, settled the question of whether 
children can participate in NTR by describing particular 
circumstances, including that the research does not pose a 
‘significant risk’. Secondly, the Act has clarified when children 
can consent independently to NTR by requiring parental/ 
guardianship consent until majority is reached. 
Problems with ministerial consent for 
all forms of NTR
Although the Act clarifies a number of issues it also creates 
new problems by requiring ministerial consent for all NTR 
involving minors regardless of risk level. As prior uncertainties 
with non-therapeutic child research have largely been clarified 
by section 71(3), the purpose of this additional procedural 
requirement is unclear. We assume that parliament wished to 
provide additional protection for minors in high-risk research 
without direct benefits, as is provided for in other jurisdictions, 
e.g. in the US Code of Federal Regulations, an Institutional 
Review Board (IRB) may not approve non-beneficial child 
research that involves more than a minor increase over 
minimal risk. In this case, the research must be approved by 
the Secretary of the Department of Health and Human Services 
after expert consultation and public comment.12
However our ministerial consent requirement would apply 
to all forms of NTR with minors. The Act defines health 
research very broadly, including any research that contributes 
to knowledge of biological, clinical, psychological or social 
processes in human beings. The Act does not define NTR. 
However, in the literature it has been defined as research that 
seeks generalisable knowledge but does not intend to benefit 
the individual directly.13,14 This means that some low-risk 
research (like certain social science research) would require 
ministerial consent. We argue that this protection is overly 
broad. Low or no-risk research does not warrant additional 
scrutiny or protection in the form of ministerial consent. For 
example, under this system a study of children’s perceptions of 
traffic hazards would require ministerial approval as it holds 
no direct benefits for these healthy participants. 
Problematic consequences
If the Minister has to consent to all NTR involving children, 
very large volumes of research will have to be reviewed, 
including social-behavioural research and student projects. 
For example, just one REC at the Human Sciences Research 
Council reviews on average 36 protocols involving minors 
every year, many of which hold out no prospect of direct 
benefit. Given that all universities and science councils are 
undertaking some child research, it is possible that the Minister 
may have to review hundreds of protocols per year. 
If ministerial consent is not provided, researchers may: (i) 
elect not to proceed; (ii) make amendments and re-submit; or 
(iii) ask the High Court to review the minister's decision. 
An unintended consequence of this provision may be 
to discourage researchers from conducting NTR involving 
minors. Researchers are also likely to question the value of 
additional scrutiny of low-risk research, which may engender 
ill will about the beauracratisation of ethics. Researchers may 
misclassify research as ‘therapeutic’ to avoid this process, or 
their legal obligations.
Possible solutions
We argue that the current provision needs amendment 
if, firstly, it is to be meaningful and add value to the 
review process, and secondly, if it is to be administratively 
manageable. We suggest three possible solutions. The first two 
are radical and the remaining one is pragmatic. 
1. Replace section 71 with comprehensive legislation 
regulating child research.
Many shortcomings have been identified with the way in 
which section 71 regulates research involving minors, e.g. it 
is based on the controversial notion of classifying research 
into therapeutic and NTR.15 Radical law reform may be an 
opportunity to develop comprehensive legislation for child 
research (not only health research) and to locate it more 
appropriately in the Children’s Act (Act No. 38 of 2005).16 This 
would, however, require political commitment. 
2. Make minor amendments to the Act to narrow the scope 
of ministerial consent to research that cannot be approved by 
an REC in terms of national ethical guidelines. 
In the US system for federally funded research, only 
research that cannot be approved by an REC must be referred 
to the Secretary for Health and Human Services. In our 
ethical-legal framework we have no mechanism to facilitate 
additional scrutiny and approval of such studies. We suggest 
that section 73 of the Act be amended to bring it in line with 
the US system for federally funded research, which has 
been created to deal with exceptional research rather than 
all non-beneficial research. This proposed amendment deals 
directly with the problem by limiting ministerial consent to 
studies where additional protection is required for under-age 
participants involved in low-benefit high-risk research. It 
means that such exceptional research may nevertheless take 
place in South Africa as the Minister is given the authority to 
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allow such research in specific circumstances. It reduces the 
ministerial burden and would be simpler than extensive law 
reform. However, this will remain an interim solution as other 
problems with the Act will remain.
3. Delegate the Minister’s authority to consent to NTR to 
an appropriate official or body. 
Section 92(a)1 of the Act empowers the Minister to delegate 
any power given to her in terms of the Act to any person in 
the employ of the State or any council, board or committee 
established in terms of this Act. This means that the Minister 
may lawfully delegate this responsibility. This opens up 
options, including delegation of this task to the Chief Director 
of the Health Information Research and Evaluation Unit 
(HIREU) at the Department, the National Health Research 
Ethics Council (NHREC), or an REC. 
In the absence of law reform, this task could be delegated to 
the HIREU or the NHREC. However, this means that another 
committee will have to read and approve large volumes of 
non-risky research that could have been managed by a com-
petent REC. This adds no ethical value to the existing process, 
only more burden and longer delays. Also, it is not within the 
NHREC’s mandate to review protocols.1
Alternatively this task could be delegated to RECs. RECs are 
in effect already performing this task so there is therefore no 
additional workload for them. However it would mean that 
RECs have to perform two different functions with regard to 
the same protocol, namely they would have to establish if it 
was ethical and if it met the public policy criteria described 
in the Act. Also, RECs will still not be able to approve certain 
categories of research. 
Conclusions 
Section 71 of the Act is a step forward in that it clarifies the 
circumstances in which non-therapeutic child research is 
lawful, which could facilitate critical public health research. 
However, important gains are undermined by an overly 
broad requirement for ministerial consent for all forms of non-
therapeutic child research. 
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